Table 4.

Summary of cost and outcome results in China

	Treatment			Incremental
Results	ANA	F&A	FUL	F&A versus ANA	F&A versus FUL
Total cost, US$	45 520.64	57 921.76	70 182.54	12 401.12	−12 260.78
Overall LYs	4.562	5.728	5.378	1.166	0.35
Total QALYs	2.786	3.578	3.434	0.792	0.144
ICER, US$
Per LY				10 635.61	−3 50 308.09
Per QALY				15 665.89	−85 144.33

F&A, half-dose fulvestrant plus anastrozole treatment group; FUL, fulvestrant;

ANA, anastrozole; LYs, life-years; QALYs, quality-adjusted life years;

ICER, incremental cost-effectiveness ratio;